Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2025-12-30 @ 8:23 PM
Study NCT ID:
NCT01390792
Status:
COMPLETED
Last Update Posted:
2017-05-16
First Post:
2011-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-07
First Submit QC Date:
None
Study First Post Date:
2011-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-05-16
Last Update Post Date Type:
ACTUAL